Skip to main content
MBIO logo

Mustang Bio, Inc.

MBIONASDAQHealthcareBiotechnology

$0.38Today:- (-)1Y −74.26%

As of Oct 16, 2026 close

Market cap
$2.60M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.37$1.69
Volume (live)
-
Avg. volume (3M)
38.38K

Mustang Bio (MBIO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Mustang Bio reported total assets of $17.59M and total liabilities of $8.06M. Shareholders' equity was $9.53M. Total debt stood at $0.00 against $17.27M in cash and short-term investments, a net cash position of $17.27M. That puts debt-to-equity at 0.00.

Mustang Bio Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Mustang Bio, Inc. (MBIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents17.276.846.2375.66109.6297.8061.4116.4734.98
Short-Term Investments0.000.000.000.000.000.000.0017.6026.00
Cash & Short-Term Investments17.276.846.2375.66109.6297.8061.4134.0760.98
Accounts Receivable0.220.403.880.000.050.020.020.040.11
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets0.111.371.233.202.041.721.631.020.28
Total Current Assets17.598.6111.3578.85111.7199.5363.0635.1361.36
Non-Current Assets
Property, Plant & Equipment (Net)0.000.454.8112.3112.109.129.136.861.38
Long-Term Investments0.000.000.000.000.000.001.000.500.50
Other Non-Current Assets0.000.251.581.261.361.250.250.270.25
Total Non-Current Assets0.000.706.4013.5713.4610.3710.387.632.13
Total Assets17.599.3117.7492.42125.17109.9073.4542.7563.49
Current Liabilities
Accounts Payable3.5112.156.326.833.513.521.881.393.47
Short-Term Debt0.000.460.520.610.350.281.510.000.00
Accrued Liabilities1.883.097.797.023.645.36---
Deferred Revenue0.150.000.000.000.000.000.000.000.00
Other Current Liabilities4.251.608.537.660.555.724.394.230.14
Total Current Liabilities7.9112.6115.3715.1110.829.527.775.623.61
Non-Current Liabilities
Long-Term Debt0.000.421.9830.771.691.9514.020.000.00
Other Non-Current Liabilities0.150.150.000.270.270.000.000.740.05
Total Non-Current Liabilities0.150.572.2531.041.961.9514.020.740.05
Total Liabilities8.0613.1817.6246.1512.7711.4721.796.363.66
Stockholders' Equity
Common Stock0.000.620.000.010.010.010.000.000.00
Retained Earnings-398.64-396.72-380.97-329.37-251.84-185.47-125.46-79.07-48.41
Accumulated Other Comprehensive Income0.270.610.001.114.330.004.922.099.56
Additional Paid-in Capital407.90392.23381.09374.52359.91283.90172.18113.3898.68
Shares Outstanding7.301.831.010.200.18----
Total Stockholders' Equity9.53-3.870.1246.27112.4098.4451.6536.4059.83
Total Liabilities & Equity17.599.3117.7492.42125.17109.9073.4542.7563.49

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Mustang Bio Balance Sheet

How much debt does Mustang Bio have?

Mustang Bio had total debt of $0.00 as of Dec 31, 2025, against $17.27M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $878.00K a year earlier.

What are Mustang Bio's total assets?

Mustang Bio reported total assets of $17.59M as of Dec 31, 2025, up 89.0% from $9.31M a year earlier. Total liabilities were $8.06M.

What is Mustang Bio's shareholders' equity?

Mustang Bio's shareholders' equity was $9.53M as of Dec 31, 2025, or about $1.31 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition